26 November 2025 in Physics in Medicine & Biology
Objective. While FLASH radiotherapy is known to reduce skin damage in vivo from ultra-high dose rate (UHDR) irradiation relative to conventional dose rates (CDR), it is not clear whether this sparing is preserved when delivered as fractionated. This study was designed to directly assess whether three daily fractions would maintain the sparing effects in murine leg models and preserve the murine skin sparing with single fraction treatments. Approach. C57Bl/6j female mice were irradiated with 9 MeV UHDR and CDR beams from a FLASH-capable Mobetron system, in a dose escalation study with doses ranging from single dose 22–30 Gy in a single fraction to three daily fractions of 10–16 Gy. The biological responses were scored by a visual skin damage response rubric using up to 5 blinded observers, and a leg contracture assay as a secondary measure of damage. Main results. There was a monotonic dose response in all treatment groups with irradiation dose, with skin damage onset at 9–10 d. In the single dose group a significant FLASH sparing was seen with a FLASH modifying factor (FMF) of approximately 0.73. Similarly in the single dose groups there were significant leg contracture differences between UHDR and CDR groups after 12–15 d. In comparison, there was no significant skin damage sparing between UHDR and CDR in the three daily fraction dose groups, and reduced sparing in the leg contracture assay. Significance. The results of this murine study show a significant reduction of the FLASH effect when the dose is split into three fractions of 10–16 Gy each, whereas there were substantial FLASH sparing effects noted for the single fractions of 22–30 Gy, showing a FMF of ∼0.73. These observations provide the data needed to optimize FLASH sparing experiments in further translational studies.
24 March 2026 in Physics in Medicine & Biology
Objective: While FLASH radiotherapy (FLASH-RT) is recognized for normal tissue sparing, its effect in mitigating the toxicity of late-responding organs remains uncertain, limiting clinical adoption. With its clinical importance and steep dose-response, spinal cord is an ideal model for evaluating the FLASH effect on late toxicity. This work introduces a robust image-guided research platform for high-precision irradiation at both conventional (CONV) and ultra-high dose rates (UHDR) to enable FLASH late toxicity studies using a rat spinal cord model. Approach: A modified LINAC was employed to irradiate the C1-T2 rat spinal cord with 18 MeV UHDR and CONV beams. A custom rat immobilization device, a portable X-ray imaging system, and an ion-chamber-based UHDR output monitoring system were integrated to ensure accurate C1-T2 localization and precise dose delivery. A Monte Carlo (MC) dose engine was developed to provide accurate dosimetry and support the interpretation of in vivo results. Scintillator measurements at UHDR were performed within the spinal cord to verify MC results and the precision of our platform. Results: We observed submillimeter deviation in C1–T2 localization between 2D X-ray and 3D CBCT imaging, as well as between pre- and post-irradiation 2D X-ray assessments. Ion chamber readings showed linear correlation with UHDR output (R 2 =1).MC calculations indicated uniform irradiation (<5% non-uniformity) along the central ~13 mm cord, avoiding dose-volume effect. Our CONV beam exhibited dose distribution close to that of the UHDR beam, with difference <3%, isolating dose rate as the only variable. Scintillator measured dose agreed with MC within 4%, with a 100% gamma passing rate (2%/2 mm), confirming both MC accuracy and the platform's high-precision delivery. Significance: We developed the first comprehensive, image-guided preclinical platform for accurate UHDR and CONV irradiation to investigate FLASH-mitigated spinal cord toxicity in rats. This work thus establishes a robust foundation for systematic evaluation of the FLASH effect in late-responding organs and for assessing relevant clinical applicability of FLASH-RT.